Navigation Links
Genomma Lab Reaffirms Zero Ownership Stake in the Laser Hair Removal Chains Neoskin and Depilite
Date:11/11/2008

MEXICO CITY, Nov. 11 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma" or "the Company"), a leading Mexican over-the-counter ("OTC") pharmaceuticals and personal care products company announced today that it owns no shares in the laser hair removal chain "Neoskin," which has recently been the subject of negative news reports. Furthermore, Genomma reiterates that in March 2008, it divested all its shares of Global Administrator, S.A. de C.V., the firm which independently operates various companies, including the stores that offer laser hair removal services under the brand "Depilite."

Genomma Lab announces the above in order to clarify its disassociation with these operations and reiterates that it has no plans to participate in the laser hair removal business in the future.

The Company continues with its current business plan and expects to communicate its 2009 growth plans in the coming weeks.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing over-the-counter pharmaceutical and personal care products companies in Mexico, and has a growing international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

Genomma Lab performed its Initial Public Offering in June, 2008, through a combined offering (mainly primary) and is listed on the Mexican Stock Exchange under the ticker symbol "LAB.B" (Bloomberg: labb.mx).

In its third quarter report of 2008, Genomma Lab reported Sales for the first nine months of 2008 of Ps. $ 1,891 million, an EBITDA of Ps. $ 470 million, a Net Consolidated Income of Ps. $ 320 million and cash and equivalents of Ps. $ 1,073 million.

Web Site: http://www.genommalab.com


'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares.
2. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
3. Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals
4. IPC The Hospitalist Company, Inc. Reaffirms Guidance for 2008
5. Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
6. Study Reaffirms Superiority of Trofile(TM) Assay
7. Vyta Corp Acquires 100% Ownership of BIOAGRA, LLC
8. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
9. China Sun Group High-Tech Co. Completes Share Exchange to Create 100% Ownership in DLX Subsidiary
10. CuraGen Sells Ownership of Belinostat to TopoTarget A/S
11. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016 On Monday, ... call to industry to share solutions for the Biometric ... U.S. Customs and Border Protection (CBP), explains that CBP ... are departing the United States , ... and to defeat imposters. Logo - ...
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
Breaking Biology News(10 mins):